WAHCEF-CV

Max Pharma‘s WAHCEF-CV is a combination antibiotic containing Cefixime (a third-generation cephalosporin) and Potassium Clavulanate (a beta-lactamase inhibitor). This potent formulation is designed to treat a wide range of bacterial infections, especially those resistant to standard antibiotics.

Cefixime works by inhibiting the synthesis of bacterial cell walls, effectively stopping the growth of bacteria. However, some bacteria produce enzymes called beta-lactamases that can inactivate cefixime. To counter this, Potassium Clavulanate is included, which binds and inactivates these enzymes, restoring the antibacterial effectiveness of cefixime.

Key Indications:

WAHCEF-CV is effective in the treatment of:

• Respiratory tract infections (bronchitis, pneumonia)

• Urinary tract infections (UTIs)

• ENT infections (sinusitis, pharyngitis, tonsillitis, otitis media)

• Skin and soft tissue infections

• Gonorrhea and other sexually transmitted bacterial infections

Benefits of WAHCEF-CV:

• Broad-spectrum antibacterial activity

• Enhanced resistance against beta-lactamase-producing organisms

• Suitable for infections where first-line antibiotics have failed

• Convenient oral tablet formulation

Directions for Use:

• Take as prescribed by your physician.

• Usually taken once or twice daily, with or without food.

• Complete the full course even if symptoms improve to avoid resistance.

Caution:

• Not recommended for patients with a known allergy to cephalosporins or penicillins.

• Use with caution in patients with kidney or liver impairment.

• Inform your doctor about other medications you’re taking to avoid interactions.

WAHCEF-CV offers a reliable and advanced solution for managing complicated infections by combining the strength of cefixime with the protective action of clavulanate, ensuring maximum therapeutic effectiveness.